Abstract 13154: Cardiovascular Risk in Users of Mirabegron Relative to Users of Antimuscarinic Treatments for Overactive Bladder: Findings From a Non-interventional, Real-world Data Safety Study

Authors: Veena Hoffman, Jesper Hallas, Marie Linder, Andrea Margulis, Brandon T Suehs, Alejandro Arana, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susana Perez Gutthann, Yihua Xu, Nina S Kristiansen, Kwame Appenteng, Stefan de Vogel, John D Seeger

Published: 2021-05-10

DOI: 10.1161/circ.142.suppl_3.13154

Source: Full article

---

Abstract

Introduction: